Looking for an examination copy?
This title is not currently available for examination. However, if you are interested in the title for your course we can consider offering an examination copy. To register your interest please contact email@example.com providing details of the course you are teaching.
Some developing biotechnologies challenge accepted legal and ethical norms because of the risks they pose. Xenotransplantation (cross-species transplantation) may prolong life but may also harm the xeno-recipient and the public due to its potential to transmit infectious diseases. These trans-boundary diseases emphasise the global nature of advances in health care and highlight the difficulties of identifying, monitoring and regulating such risks and thereby protecting individual and public health. Xenotransplantation raises questions about how uncertainty and risk are understood and accepted, and exposes tensions between private benefit and public health. Where public health is at risk, a precautionary approach informed by the harm principle supports prioritising the latter, but the issues raised by genetically engineered solid organ xenotransplants have not, as yet, been sufficiently discussed. This must occur prior to their clinical introduction because of the necessary changes to accepted norms which are needed to appropriately safeguard individual and public health.Read more
- Explores whether xenotransplantation can be accommodated within existing legal and ethical norms and looks at the legal and ethical, practical implications of allowing clinical genetically engineered solid organ xenotransplants
- Considers how risks are and can be regulated, particularly in situations of uncertainty and/or ignorance
- International and comparative aspects of the analysis facilitate the learning of relevant lessons from selected jurisdictions
Be the first to review this book
- Date Published: December 2011
- format: Hardback
- isbn: 9780521195768
- length: 306 pages
- dimensions: 235 x 155 x 15 mm
- weight: 0.6kg
- availability: In stock
Table of Contents
1. Introducing the issues
2. Dealing with risk
3. Regulating experimental procedures and medical research
4. Regulatory responses to developing biotechnologies
5. Challenges to legal and ethical norms: first party consent and third parties at risk
6. Surveillance and monitoring: balancing public health and individual freedom
7. Looking to the future.
You are now leaving the Cambridge University Press website, your eBook purchase and download will be completed by our partner www.ebooks.com. Please see the permission section of the www.ebooks.com catalogue page for details of the print & copy limits on our eBooks.Continue ×